How to Use ISO 13485 Certificates for Overseas Registration of Laboratory Equipment

Published: August 25, 2026 | Updated: August 25, 2026 | Source: AIMEILI Regulatory Knowledge Base

Key Summary

The ISO 13485 certificate is not a sufficient condition for product registration but rather evidence of a quality management system. Companies must first determine whether the laboratory equipment qualifies as a medical device in the target country, its risk class, and the applicable registration pathway. The certificate can support the quality system section of a technical file, but it generally cannot replace a product registration certificate. To achieve successful registration, manufacturers must prepare a full set of documents including the technical file, risk management report, performance verification data, clinical evaluation or literature evidence, and labeling in the local language. In GHWP member countries, Southeast Asia, the Middle East, and Latin America, appointing a local agent or authorized representative is mandatory, along with obtaining the required licenses. Common risks include misunderstanding the certificate as a sales permit, failing to distinguish product classification, missing local-language labeling, and overlooking post-market surveillance requirements. Companies should build a core technical file pool, tailor it for each target market, and manage certificate control, change notifications, and renewal processes in advance to reduce repeated document preparation and correction requests across multiple countries.

Applicable Scenarios and Core Questions

Laboratory equipment typically includes analytical instruments, sample processing devices, diagnostic instruments, and auxiliary consumables. Regulatory classifications vary significantly across countries. Some products are classified as in vitro diagnostic (IVD) medical devices in the EU, medical devices in the US, and ordinary laboratory instruments in certain Southeast Asian countries. Therefore, after obtaining an ISO 13485 certificate, manufacturers should not treat it as a universal product registration pass. Instead, they must clarify the legal definition in the target market.

The core questions are: Is the laboratory equipment considered a medical device in the target country? If yes, what is the risk class and the required market authorization pathway? What role does the ISO 13485 certificate play in that pathway? Answering these three questions determines the technical file, quality system documentation, and registration strategy.

For example, PCR analyzers, biochemistry analyzers, and immunoassay analyzers used for clinical testing are generally considered IVD medical devices or accessories. In contrast, laboratory equipment intended solely for research and not for clinical diagnosis may be exempt from registration in many countries, but still must meet basic electrical safety and electromagnetic compatibility requirements. Manufacturers should always verify the intended use and clinical purpose descriptions, as these define the regulatory boundary.

Registration Decision Logic

The decision logic for overseas registration of laboratory equipment follows four steps.

Step 1: Confirm Regulatory Status

Determine whether the target country regulates the product as a medical device or IVD. Review the medical device classification list issued by the national health authority, or reference the Global Medical Device Nomenclature (GMDN) and GHTF classification principles. For example, the US FDA classifies IVD products under 21 CFR 862-866, the EU follows IVDR 2017/746, and GHWP member countries may adopt IMDRF-based frameworks.

Step 2: Determine Risk Class

Risk classification differs by country, commonly using categories such as Class A/B/C/D or Class I/II/III. The class directly affects the registration route. Low-risk devices may qualify for self-declaration or simplified registration, while medium- and high-risk devices require full technical documentation, possibly including quality system audits or clinical evaluation.

Step 3: Assess Reusability of Existing Documentation

Take an inventory of existing approvals and reports such as NMPA registrations, CE certificates, FDA 510(k)/PMA clearances, ISO 13485 certificates, MDSAP certificates, product test reports, stability studies, and performance verification data. For GHWP member states, Southeast Asia, the Middle East, and Latin America, technical content is often highly reusable, but report formats, languages, and test standards may require localization.

Step 4: Confirm Applicant and Agent Responsibilities

Most non-local manufacturers must appoint a local authorized representative or agent responsible for submitting the application, responding to deficiencies, and handling post-market surveillance. The ISO 13485 certificate holder is usually the manufacturer, but the applicant's name, address, and authorized scope must be consistent with the certificate information to avoid discrepancies.

Documentation and Evidence

The ISO 13485 certificate must be used together with other documents to form a complete chain of evidence. Compile a technical file index and include a copy or scan of the ISO 13485 certificate in the quality management system section.

Typical baseline documents include:

• Business license or registration proof of the company
• ISO 13485 certificate
• Product description and intended use
• Product classification declaration
• Labels and instructions for use
• Risk management report (per ISO 14971)
• Design and development documentation summary
• Performance verification reports or third-party test reports
• Electrical safety and electromagnetic compatibility reports (if applicable)
• Software verification reports (if software is included)
• Stability study data
• Clinical data or literature evaluation
• Sterilization validation reports (if applicable)

In some GHWP member countries, product test reports must be issued by a nationally recognized laboratory or meet accepted standards. The ISO 13485 certificate can demonstrate manufacturing capability but cannot replace third-party test reports. Confirm early which reports need to be generated locally and which may accept CB reports or CNAS reports from overseas laboratories.

Labels and instructions are often overlooked. The ISO 13485 certificate does not prove that label content meets target country language and regulatory requirements. Develop labels in the local language, including product name, model, registrant, manufacturer, importer, instructions, and hazard warnings. In Southeast Asia, the Middle East, and Latin America, languages such as Indonesian, Thai, Arabic, Spanish, and Portuguese require careful translation and localization planning.

Post-market maintenance documents are also part of the evidence chain. Registration certificates are usually valid for one to five years, during which periodic reports, adverse event reports, label updates, and change notifications may be required. Establish a post-market surveillance program under the ISO 13485 system and retain records for submission during renewal or changes.

Common Mistakes

• Misinterpreting the ISO 13485 certificate as a product registration certificate, and marketing the product for clinical use, resulting in sales prohibitions or fines.
• Ignoring the target country's product classification, exporting IVD products as ordinary laboratory equipment without registration documents.
• Failing to appoint a local agent, or the agent's qualifications do not meet requirements, causing application rejection or delays.
• Submitting technical files in English to countries that require local translation, such as Brazil, Russia, and China, leading to formal review failure.
• Labels and instructions not in the target country language, or missing mandatory information such as registrant, manufacturer, and importer.
• Incomplete risk management reports that do not cover all intended uses and reasonably foreseeable misuse scenarios per ISO 14971.
• Performance verification reports based on test standards not accepted in the target country (e.g., using IEC standards while the US or Southeast Asia requires ASTM or ISO standards).
• The company name on the ISO 13485 certificate does not match the registration applicant, and no legal authorization relationship is provided.
• Neglecting post-market surveillance obligations, failing to establish adverse event collection and reporting procedures, leading to renewal failure.

Company Preparation Checklist

• Verify whether the target country regulates the laboratory equipment as a medical device, and confirm the risk class and registration pathway.
• Review the scope and validity of the existing ISO 13485 certificate to ensure it covers the product type and manufacturing activities.
• Build a core technical file repository including product description, intended use, classification rationale, design inputs/outputs, and risk management documents.
• Prepare performance verification reports, third-party test reports, and stability data, and check if test standards are recognized by the target country.
• Create labels and instructions for use that comply with target country regulations, including local language and required regulatory information.
• Appoint a local authorized representative or agent, execute a formal authorization letter, and clearly define responsibilities.
• Verify that the manufacturer name and address on the ISO 13485 certificate match the registration application materials exactly.
• Plan post-market surveillance procedures, including adverse event reporting, annual compliance updates, recall processes, and training records.
• Set priorities for document reuse and localization based on your multi-country registration plan to avoid redundant work.
• Proactively communicate with target country regulators or agents about deficiency management, and allocate sufficient review time.

AIMEILI Regulatory Interpretation and Business Impact

The most common misjudgment is treating the ISO 13485 certificate as a license to freely sell the product. It must be emphasized: the certificate is evidence of a quality system, not a product license. Even in countries that accept ISO 13485 as part of the registration dossier, regulators independently review the technical file, test reports, and clinical data. Therefore, the early focus of project management should be regulatory status determination and gap analysis, rather than simply reusing existing documents.

The time most worth investing up front is determining the regulatory classification and registration path. We recommend conducting a target country regulatory scan to clarify whether the product is a medical device, IVD, or general laboratory equipment, and then mapping the submission requirements according to risk class. This step avoids a large amount of non-value-added work downstream.

In document preparation, ISO 13485 certificates, CE technical files, FDA 510(k) submissions, and MDSAP audit reports are often highly reusable in many countries, especially performance verification, risk management, software validation, and stability reports. However, labels, instructions, packaging, local agent documents, language translations, and certain test reports must be localized. Do not treat any test report as globally valid; always verify each target country's requirements for testing laboratory accreditation.

Local agents and control over certificates play a strategic role in multi-country registrations. The manufacturer must ensure that the ISO 13485 certificate is in the name of the final production entity and clearly authorize the local agent to use the certificate for submission. During changes, renewals, and adverse event handling, the agent must receive timely certificate updates; otherwise, registration information may become inconsistent with actual status. We recommend that service agreements with agents include obligations for certificate renewal notifications, change application deadlines, and handover arrangements upon termination.

The biggest pain point in multi-country registration is repeatedly modifying the same set of documents—both time-consuming and error-prone. A better approach is to create a master core file set containing all foundational technical and quality data, then localize the packaging for each country. When a target country raises deficiency questions, determine whether the issue stems from missing core data or merely requires format adjustment. This minimizes correction risk and improves the efficiency of parallel submissions across markets.

Frequently Asked Questions

Can an ISO 13485 certificate be used directly for FDA registration in the US?

No. The FDA does not accept ISO 13485 as a substitute for compliance with 21 CFR 820 (Quality System Regulation). The certificate can, however, support the quality system elements required under the FD&C Act and demonstrate that the company operates an internationally recognized quality management system during FDA inspections. For product registration, you must still file a 510(k) or PMA. The ISO 13485 certificate is only supplementary documentation.

If a product is for research use only and not for clinical diagnosis, is an ISO 13485 certificate still necessary?

If the target country explicitly excludes research-only products from medical device regulation, a medical device registration application is generally not required. However, the product must still comply with universal regulations such as electrical safety, electromagnetic compatibility, and hazardous substance restrictions. An ISO 13485 certificate may not be mandatory, but it can be a competitive advantage in customer tenders or quality audits. Decide based on customer requirements whether to maintain and present the certificate.

Are there any special requirements for ISO 13485 certificates in GHWP member countries?

GHWP members generally recognize ISO 13485 as the quality management system basis, but they may have varying requirements on certificate issuing bodies, translation notarization, and validity periods. Some countries require the certificate to be issued by an accredited certification body and translated into the official language with notarization. Additionally, some regulators review whether the certificate's scope specifically covers the target product. When preparing for multi-country registration, request a certificate attachment from your certification body that lists the product category and covered scope to reduce deficiencies.

Continue Reading

• How to Prepare Clinical Evaluation Documentation for Overseas Registration of Laboratory Equipment
• What to Do When Quality System Evidence Is Inconsistent for Implantable Devices
• Recommended Reading: Selecting a Local Agent for Patient Monitoring Equipment Overseas Registration
• Risk Management Documentation Requirements for Rehabilitation Equipment Overseas Registration
• How to Use ISO 13485 Certificates for Implantable Products Overseas Registration
• Preparing Performance Verification Data for Imaging Equipment Overseas Registration
• Performance Verification Documentation for AI Medical Devices Overseas Registration
• How to Prepare Registration Documentation for Active Medical Devices Overseas Registration

Content Review and Applicability

Content author: AIMEILI Regulatory Editorial Team | Professional review: AIMEILI Medical Device International Registration Project Team | Source principle: Priority is given to official regulatory bodies, international organizations, standard organizations, and publicly available regulatory materials; industry media and project experience serve only as supporting judgment.

Applicability: This article is intended for preliminary understanding, document preparation, and project planning. It does not replace the official requirements of target country regulatory authorities, test conclusions, or legal advice.